Vichy Laboratoires Recalls LiftActiv Peptide

The glass packaging of the small, sealed vials (ampoules) can weaken over time and break when opened, posing a laceration hazard to fingers and hands.

About 206,200

Vichy Laboratoires USA toll-free at 844-973-0595 from 9 a.m. to 5 p.m. ET Monday through Friday or online at https://www.vichyusa.com/customer-service/contact-us.html or www.vichyusa.com and click on Customer Service and then on “RECALL INFORMATION” for more information.

This recall involves Liftactiv Peptide-C Ampoules 1.8ml (10 pack) and Liftactiv Peptide-C Ampoules 1.8ml (30 pack) which are facial serums. The serum is packaged in amber-colored glass ampoules with the following batch numbers: 54T61Q, 54T91Q, 54TD1Q, 54TD2Q, 54TN1Q, 54TN2Q, 54TN3Q, 54TO1Q, 54U11Q, 54U12Q, 54U21Q, 54U31Q, 54U32Q, 54U41S, 54U42S, 54U51S, 54U52S,54U53S,54U54S,54U61S, 54U72S, 54U91S, 54U62S, 54U92S, 54UD1S, 54UO1S, 54W11S, 54W12S, 54W13S, 54W21S. The batch number is printed on the bottom or side of the pack.

Consumers should immediately stop using the recalled product and contact Vichy USA Consumer Care for a full refund. The firm is contacting all known purchasers.

The firm has received 35 reports of injuries, including one injury involving a cut to a person’s hand requiring stitches.

Note: Individual Commissioners may have statements related to this topic. Please visit www.cpsc.gov/commissioners to search for statements related to this or other topics.

The recalled dietary supplements contain iron which must be in child-resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child-resistant, posing a risk of poisoning if the contents are swallowed by young children.

The recalled products contain diphenhydramine hydrochloride and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

The cord on the hair stylers can detach if the unit is dropped, posing an electrocution or shock hazard to users.

The products contain sodium hydroxide or potassium hydroxide which must be in child resistant packaging, as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of chemical burns and irritation to the skin and eyes. In addition, the label on the product violates the Federal Hazardous Substance Act (FHSA) by omitting the word “poison” for poisonous chemicals.

The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risk of injury or death associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product-related incidents cost the nation more than $1 trillion annually. CPSC's work to ensure the safety of consumer products has contributed to a decline in the rate of injuries associated with consumer products over the past 50 years.

Federal law prohibits any person from selling products subject to a Commission ordered recall or a voluntary recall undertaken in consultation with the CPSC.